Lymphoma Action is the UK's only charity dedicated to lymphoma, aiming to provide support for individuals affected by this type of cancer.

Lymphoma Action

Childhood Eye Cancer Trust focuses on supporting individuals affected by retinoblastoma, providing resources and information about the condition.

Childhood Eye Cancer Trust

Lymphoma Action | 1,921 followers on LinkedIn. We’re the UK&#39;s only charity dedicated to lymphoma - the most common blood cancer.
Inform | Support | Connect | We are the UK&#39;s only charity dedicated to lymphoma, the fifth most common cancer and the UK’s most common blood cancer. We’ve been providing trusted information and support for over 35 years, helping thousands of people affected by lymphoma.

Our mission is to make sure no one faces lymphoma alone.

Penny Clarke

Director of Fundraising at The Hospital of St John and St Elizabeth and St John's Hospice

Charlotte Locks-Moro

Digital, Communications & Engagement at Lymphoma Action

Ria Bowler

Retired IT Industry Professional

Mark Zymela

Lymphoma is the most common type of blood cancer. Blood cancer patients experience some of the most significant delays to diagnosis of all cancer patients - with 1/3 of patients diagnosed in an emergency setting, when their disease has progressed and outcomes are likely to be worse. We're a member of the Blood Cancer Alliance , and we want to see a new national cancer strategy that contains specific measures to address challenges in diagnosing blood cancer to help patients lead longer, better lives. #Lymphoma #BloodCancer

Are you struggling with sleep? How can you rest your mind and fall asleep? We all know how a good night's sleep feels, but what is it and what are the benefits? Dr Mike Scanlan, a retired therapist and lecturer in mental health, has written an article for us in Lymphoma Matters on ways to ensure you get a good night's sleep and why it's so important. Including steps for structured worrying, finding your sleep window and the process of letting go. Read here 👉 https://lnkd.in/eD-S4edM #Lymphoma #BloodCancer #Sleep #MentalHealth

Did you know that X-rays were discovered in 1895? Today is #WorldRadiographyDay . Initially started as a way of acknowledging the work of the physics professor WC Röntgen, who discovered X-rays, it has since developed into a broader celebration of radiography and the health professionals who work within this specialty. This year’s theme ‘Radiographers: Seeing the Unseen’ focusses on the vital role of radiographers in diagnosis and health management. Click for more and to find out about radiography in lymphoma 👉 https://lnkd.in/e9H4mmVr #Lymphoma #BloodCancer

A record-breaking 1,204 of you responded to our UK survey done in conjunction with the Lymphoma Coalition as part of their global survey on lymphomas and CLL. Today we report on the UK findings, and let you know how this will guide what we do in future. Read our summary 👉 https://lnkd.in/eaWuvyMk #Lymphoma #CLL

As you get ready for Christmas, you can help us make sure no one faces lymphoma alone. This Christmas there are lots of ways you can support us, from buying Christmas cards and other goodies, holding festive fashion days, or simply generating donations for Lymphoma Action as you shop (at no extra cost to you!). Discover more 👉 https://lnkd.in/eSsJw_7c #Lymphoma #BloodCancer #LymphomaSupport #HodgkinLymphoma #NonHodgkinLymphoma

“I remember thinking after the stem cell transplant that ‘this was it’ and I wouldn’t see my sons go to university. Thankfully I did, and the developments in science and medicine have made my remission possible. For that, I will be eternally grateful. “I have been given a lot of information and support from health professionals and resources like Lymphoma Action. This always gave me hope of a future… In 2018, we went to a Lymphoma Action conference… here, we learnt about CAR-T cell therapy and different types of lymphoma from leading haematologists. Little did we know that these consultants would actually be involved in my future treatment plan!” Rachel shares her experience of lymphoma and Car-T cell therapy 👉 https://lnkd.in/ei4nqmZ9 #Lymphoma #BloodCancer #DLBCL #FollicularLymphoma #CARTCellTherapy

To everyone who joined #TeamLymphoma and fundraised this month - thank you! Lymphoma is the UK's most common type of blood cancer and it's thanks to your support that we can make sure that no one faces it alone. 💜 #Lymphoma #BloodCancer

Hear about our Corporate Partnerships Manager role from Amy. Find out more 👉 https://lnkd.in/gT2CM9Ry #CharityJob #FundraisingJob #CorporatePartnerships

The initial findings of the first ever national non-Hodgkin lymphoma audit are now available. Read more 👉 https://lnkd.in/eCiBWzCS The National Non-Hodgkin Lymphoma Audit (NNHLA), which is part of the National Cancer Audit Collaborating Centre (NATCAN) , is evaluating the patterns of care and outcomes for people diagnosed with non-Hodgkin lymphoma (NHL) in England and Wales. It is a fantastic opportunity to make a lasting difference to people diagnosed with NHL, which we are very proud to be involved with. #Lymphoma #NonHodgkinLymphoma #BloodCancer

Sickness can be a side effect of some treatments for lymphoma. This could mean feeling sick (nausea), being sick (vomiting), or retching (dry heaves). Find out about anti-sickness medication, non-drug treatments and answers to frequently asked questions 👉 https://lnkd.in/eBTfNqsV #Lymphoma #BloodCancer

Metric
Company Name	Lymphoma Action	Childhood Eye Cancer Trust
Symbol
MSH ID	UK:ORG:LYMPHOMA-ACTION	UK:ORG:CHECT
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services
Industry	Non-profit healthcare	Non-profit organization
Country	GB	GB
Stage
Employee Count
Website	lymphoma-action.org.uk	chect.org.uk
LinkedIn	lymphoma-action	childhood-eye-cancer-trust
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic		216
Web Traffic Growth		0.79
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

UK:ORG:LYMPHOMA-ACTION

Lymphoma Action

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue